Understanding epigenetic architecture of suicide neurobiology: A critical perspective

Neuroscience and Biobehavioral Reviews

Volumn 72, Issue , 2017, Pages 10-27

  Roy, Bhaskar ^a   Dwivedi, Yogesh ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

DNA methylation; Epigenetics; Gene expression; Histone modification; Suicide

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR ALPHA1; ANTIZYME; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; DNA METHYLTRANSFERASE; DNA METHYLTRANSFERASE 3B; EPIDERMAL GROWTH FACTOR RECEPTOR 3; GAP JUNCTION PROTEIN; MESSENGER RNA; NEUROTROPHIN; POLYAMINE OXIDASE;

3' UNTRANSLATED REGION; AUTOPSY; BIPOLAR DISORDER; CPG ISLAND; DNA METHYLATION; DOWN REGULATION; ENDOPHENOTYPE; EPIGENETICS; GABAERGIC SYSTEM; GAP JUNCTION; GENE CONTROL; GENE EXPRESSION; GENE MAPPING; GLIA CELL; HISTONE MODIFICATION; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAJOR DEPRESSION; MONOAMINERGIC SYSTEM; NERVE CELL PLASTICITY; NEUROBIOLOGY; NEUROIMAGING; NEUROTRANSMISSION; PATHOPHYSIOLOGY; PHENOTYPE; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN CONFORMATION; REVIEW; RISK FACTOR; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SUBSTANCE ABUSE; SUICIDAL BEHAVIOR; SUICIDE; GENETIC EPIGENESIS;

DNA METHYLATION; EPIGENESIS, GENETIC; EPIGENOMICS; HUMANS; SUICIDE;

EID: 84995802716     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2016.10.031     Document Type: Review

References (256)

1. Aliperti, V., Donizetti, A., Long non-coding RNA in neurons: new players in early response to BDNF stimulation. Front. Mol. Neurosci., 9, 2016, 15.
2. Allen, N.J., Astrocyte regulation of synaptic behavior. Annu. Rev. Cell Dev. Biol. 30 (2014), 439–463.
3. Altshuler, L.L., Abulseoud, O.A., Foland-Ross, L., Bartzokis, G., Chang, S., Mintz, J., Hellemann, G., Vinters, H.V., Amygdala astrocyte reduction in subjects with major depressive disorder but not bipolar disorder. Bipolar Disord. 12 (2010), 541–549.
4. Appel, K., Schwahn, C., Mahler, J., Schulz, A., Spitzer, C., Fenske, K., Stender, J., Barnow, S., John, U., Teumer, A., Biffar, R., Nauck, M., Volzke, H., Freyberger, H.J., Grabe, H.J., Moderation of adult depression by a polymorphism in the FKBP5 gene and childhood physical abuse in the general population. Neuropsychopharmacology 36 (2011), 1982–1991.
5. Araque, A., Parpura, V., Sanzgiri, R.P., Haydon, P.G., Tripartite synapses: glia, the unacknowledged partner. Trends Neurosci. 22 (1999), 208–215.
6. Araque, A., Carmignoto, G., Haydon, P.G., Oliet, S.H., Robitaille, R., Volterra, A., Gliotransmitters travel in time and space. Neuron 81 (2014), 728–739.
7. Arnett, M.G., Muglia, L.M., Laryea, G., Muglia, L.J., Genetic approaches to hypothalamic-pituitary-Adrenal axis regulation. Neuropsychopharmacology 41 (2016), 245–260.
8. Arosio, B., D'Addario, C., Gussago, C., Casati, M., Tedone, E., Ferri, E., Nicolini, P., Rossi, P.D., Maccarrone, M., Mari, D., Peripheral blood mononuclear cells as a laboratory to study dementia in the elderly. BioMed Res. Int., 2014, 2014, 169203.
9. Autry, A.E., Monteggia, L.M., Epigenetics in suicide and depression. Biol. Psychiatry 66 (2009), 812–813.
10. Autry, A.E., Monteggia, L.M., Brain-derived neurotrophic factor and neuropsychiatric disorders. Pharmacol. Rev. 64 (2012), 238–258.
11. Bani-Fatemi, A., Howe, A.S., De Luca, V., Epigenetic studies of suicidal behavior. Neurocase 21 (2015), 134–143.
12. Bani-Fatemi, A., Howe, A.S., Matmari, M., Koga, A., Zai, C., Strauss, J., De Luca, V., Interaction between methylation and CpG single-nucleotide polymorphisms in the HTR2A gene: association analysis with suicide attempt in schizophrenia. Neuropsychobiology 73 (2016), 10–15.
13. Barry, G., Briggs, J.A., Vanichkina, D.P., Poth, E.M., Beveridge, N.J., Ratnu, V.S., Nayler, S.P., Nones, K., Hu, J., Bredy, T.W., Nakagawa, S., Rigo, F., Taft, R.J., Cairns, M.J., Blackshaw, S., Wolvetang, E.J., Mattick, J.S., The long non-coding RNA Gomafu is acutely regulated in response to neuronal activation and involved in schizophrenia-associated alternative splicing. Mol. Psychiatry 19 (2014), 486–494.
14. Bertolote, J.M., Fleischmann, A., Suicide and psychiatric diagnosis: a worldwide perspective. World Psychiatry: Off. J. World Psychiatr. Assoc. (WPA) 1 (2002), 181–185.
15. Binder, E.B., Salyakina, D., Lichtner, P., Wochnik, G.M., Ising, M., Putz, B., Papiol, S., Seaman, S., Lucae, S., Kohli, M.A., Nickel, T., Kunzel, H.E., Fuchs, B., Majer, M., Pfennig, A., Kern, N., Brunner, J., Modell, S., Baghai, T., Deiml, T., Zill, P., Bondy, B., Rupprecht, R., Messer, T., Kohnlein, O., Dabitz, H., Bruckl, T., Muller, N., Pfister, H., Lieb, R., Mueller, J.C., Lohmussaar, E., Strom, T.M., Bettecken, T., Meitinger, T., Uhr, M., Rein, T., Holsboer, F., Muller-Myhsok, B., Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nat. Genet. 36 (2004), 1319–1325.
16. Binder, E.B., Bradley, R.G., Liu, W., Epstein, M.P., Deveau, T.C., Mercer, K.B., Tang, Y., Gillespie, C.F., Heim, C.M., Nemeroff, C.B., Schwartz, A.C., Cubells, J.F., Ressler, K.J., Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults. JAMA 299 (2008), 1291–1305.
17. Binder, E.B., The role of FKBP5, a co-chaperone of the glucocorticoid receptor in the pathogenesis and therapy of affective and anxiety disorders. Psychoneuroendocrinology 34:Suppl. 1 (2009), S186–195.
18. Blasco-Fontecilla, H., Lopez-Castroman, J., Giner, L., Baca-Garcia, E., Oquendo, M.A., Predicting suicidal behavior: are we really that far along? Comment on discovery and validation of blood biomarkers for suicidality. Curr. Psychiatry Rep., 15, 2013, 424.
19. Bockbrader, K., Feng, Y., Essential function, sophisticated regulation and pathological impact of the selective RNA-binding protein QKI in CNS myelin development. Fut. Neurol. 3 (2008), 655–668.
20. Boks, M.P., de Jong, N.M., Kas, M.J., Vinkers, C.H., Fernandes, C., Kahn, R.S., Mill, J., Ophoff, R.A., Current status and future prospects for epigenetic psychopharmacology. Epigenetics 7 (2012), 20–28.
21. Brand-Schieber, E., Lowery, S.L., Werner, P., Select ionotropic glutamate AMPA/kainate receptors are expressed at the astrocyte-vessel interface. Brain Res. 1007 (2004), 178–182.
22. Brent, D.A., Melhem, N., Familial transmission of suicidal behavior. Psychiatr. Clin. North Am. 31 (2008), 157–177.
23. Brent, D., Melhem, N., Ferrell, R., Emslie, G., Wagner, K.D., Ryan, N., Vitiello, B., Birmaher, B., Mayes, T., Zelazny, J., Onorato, M., Devlin, B., Clarke, G., DeBar, L., Keller, M., Association of FKBP5 polymorphisms with suicidal events in the Treatment of Resistant Depression in Adolescents (TORDIA) study. Am. J. Psychiatry 167 (2010), 190–197.
24. CDC, 2015. Understanding suicide: Fact sheet. https://www.cdc.gov/violenceprevention/pdf/suicide_factsheet-a.pdf.
25. Cao, X., Li, L.P., Wang, Q., Wu, Q., Hu, H.H., Zhang, M., Fang, Y.Y., Zhang, J., Li, S.J., Xiong, W.C., Yan, H.C., Gao, Y.B., Liu, J.H., Li, X.W., Sun, L.R., Zeng, Y.N., Zhu, X.H., Gao, T.M., Astrocyte-derived ATP modulates depressive-like behaviors. Nat. Med. 19 (2013), 773–777.
26. Carballo, J.J., Akamnonu, C.P., Oquendo, M.A., Neurobiology of suicidal behavior: an integration of biological and clinical findings. Arch. Suicide Res. Off. J. Int. Acad. Suicide Res. 12 (2008), 93–110.
27. Carim-Todd, L., Bath, K.G., Fulgenzi, G., Yanpallewar, S., Jing, D., Barrick, C.A., Becker, J., Buckley, H., Dorsey, S.G., Lee, F.S., Tessarollo, L., Endogenous truncated TrkB.T1 receptor regulates neuronal complexity and TrkB kinase receptor function in vivo. J. Neurosci. 29 (2009), 678–685.
28. Choi, J.K., Bae, J.B., Lyu, J., Kim, T.Y., Kim, Y.J., Nucleosome deposition and DNA methylation at coding region boundaries. Genome Biol., 10, 2009, R89.
29. Choi, M., Lee, S.H., Wang, S.E., Ko, S.Y., Song, M., Choi, J.S., Kim, Y.S., Duman, R.S., Son, H., Ketamine produces antidepressant-like effects through phosphorylation-dependent nuclear export of histone deacetylase 5 (HDAC5) in rats. Proc. Natl. Acad. Sci. U. S. A. 112 (2015), 15755–15760.
30. Cohen-Cory, S., Kidane, A.H., Shirkey, N.J., Marshak, S., Brain-derived neurotrophic factor and the development of structural neuronal connectivity. Dev. Neurobiol. 70 (2010), 271–288.
31. Currier, D., Mann, J.J., Stress, genes and the biology of suicidal behavior. Psychiatr. Clin. North Am. 31 (2008), 247–269.
32. Day, J.J., Sweatt, J.D., Epigenetic treatments for cognitive impairments. Neuropsychopharmacology 37 (2012), 247–260.
33. De Luca, V., Viggiano, E., Dhoot, R., Kennedy, J.L., Wong, A.H., Methylation and QTDT analysis of the 5-HT2A receptor 102C allele: analysis of suicidality in major psychosis. J. Psychiatr. Res. 43 (2009), 532–537.
34. Ding, Y., Lawrence, N., Olie, E., Cyprien, F., le Bars, E., Bonafe, A., Phillips, M.L., Courtet, P., Jollant, F., Prefrontal cortex markers of suicidal vulnerability in mood disorders: a model-based structural neuroimaging study with a translational perspective. Transl. Psychiatry, 5, 2015, e516.
35. Dwivedi, Y., Rizavi, H.S., Conley, R.R., Roberts, R.C., Tamminga, C.A., Pandey, G.N., Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. Arch. Gen. Psychiatry 60 (2003), 804–815.
36. Dwivedi, Y., Brain-derived neurotrophic factor: role in depression and suicide. Neuropsychiatr. Dis. Treat. 5 (2009), 433–449.
37. Dwivedi, Y., Brain-derived neurotrophic factor and suicide pathogenesis. Ann. Med. 42 (2010), 87–96.
38. Dwivedi, Y., Evidence demonstrating role of microRNAs in the etiopathology of major depression. J. Chem. Neuroanat. 42 (2011), 142–156.
39. Dwivedi, Y., microRNAs as biomarker in depression pathogenesis. Ann. Psychiatry Ment. Health, 1, 2013, 1003.
40. Dwivedi, Y., Emerging role of microRNAs in major depressive disorder: diagnosis and therapeutic implications. Dialogues Clin. Neurosci. 16 (2014), 43–61.
41. Ernst, C., McGowan, P.O., Deleva, V., Meaney, M.J., Szyf, M., Turecki, G., The effects of pH on DNA methylation state: in vitro and post-mortem brain studies. J. Neurosci. Methods 174 (2008), 123–125.
42. Ernst, C., Deleva, V., Deng, X., Sequeira, A., Pomarenski, A., Klempan, T., Ernst, N., Quirion, R., Gratton, A., Szyf, M., Turecki, G., Alternative splicing, methylation state, and expression profile of tropomyosin-related kinase B in the frontal cortex of suicide completers. Arch. Gen. Psychiatry 66 (2009), 22–32.
43. Ernst, C., Chen, E.S., Turecki, G., Histone methylation and decreased expression of TrkB. T1 in orbital frontal cortex of suicidecompleters. Mol. Psychiatry 9 (2009), 830–832, 10.1038/mp.2009.35.
44. Ernst, C., Nagy, S., Kim, J.P., Yang, X., Deng, I.C., Hellstrom, K.H., Choi, H., Gershenfeld, H., Meaney, M.J., Turecki, G., Dysfunction of astrocyte connexins 30 and 43 in dorsal lateral prefrontal cortex of suicide completers. Biol. Psychiatry 70 (2011), 312–319.
45. Ewald, E.R., Wand, G.S., Seifuddin, F., Yang, X., Tamashiro, K.L., Potash, J.B., Zandi, P., Lee, R.S., Alterations in DNA methylation of Fkbp5 as a determinant of blood-brain correlation of glucocorticoid exposure. Psychoneuroendocrinology 44 (2014), 112–122.
46. Fan, H.M., Sun, X.Y., Guo, W., Zhong, A.F., Niu, W., Zhao, L., Dai, Y.H., Guo, Z.M., Zhang, L.Y., Lu, J., Differential expression of microRNA in peripheral blood mononuclear cells as specific biomarker for major depressive disorder patients. J. Psychiatr. Res. 59 (2014), 45–52.
47. Faravelli, C., Lo Sauro, C., Godini, L., Lelli, L., Benni, L., Pietrini, F., Lazzeretti, L., Talamba, G.A., Fioravanti, G., Ricca, V., Childhood stressful events, HPA axis and anxiety disorders. World J. Psychiatry 2 (2012), 13–25.
48. Faravelli, C., Lo Sauro, C., Lelli, L., Pietrini, F., Lazzeretti, L., Godini, L., Benni, L., Fioravanti, G., Talamba, G.A., Castellini, G., Ricca, V., The role of life events and HPA axis in anxiety disorders: a review. Curr. Pharm. Des. 18 (2012), 5663–5674.
49. Fellin, T., Pascual, O., Gobbo, S., Pozzan, T., Haydon, P.G., Carmignoto, G., Neuronal synchrony mediated by astrocytic glutamate through activation of extrasynaptic NMDA receptors. Neuron 43 (2004), 729–743.
50. Felsenfeld, G., Groudine, M., Controlling the double helix. Nature 421 (2003), 448–453.
51. Fields, R.D., White matter in learning, cognition and psychiatric disorders. Trends Neurosci. 31 (2008), 361–370.
52. Fiori, L.M., Turecki, G., Implication of the polyamine system in mental disorders. J. Psychiatry Neurosci. 33 (2008), 102–110.
53. Fiori, L.M., Turecki, G., Association of the SAT1 in/del polymorphism with suicide completion. Am. J. Med. Genet. B Neuropsychiatr. Genets 153b (2010), 825–829.
54. Fiori, L.M., Turecki, G., Genetic and epigenetic influences on expression of spermine synthase and spermine oxidase in suicide completers. Int. J. Neuropsychopharmacol. 13:July 6 (2010), 725–736, 10.1017/S1461145709991167.
55. Fiori, L.M., Turecki, G., Epigenetic regulation of spermidine/spermine N1-acetyltransferase (SAT1) in suicide. J. Psychiatr. Res. 45 (2011), 1229–1235.
56. Fiori, L.M., Turecki, G., Approaches and findings from gene expression profiling studies of suicide. Dwivedi, Y., (eds.) The Neurobiological Basis of Suicide, 2012, CRC Press/Taylor & Francis, Boca Raton (FL) (Frontiers in Neuroscience).
57. Fiori, L.M., Bureau, A., Labbe, A., Croteau, J., Noel, S., Merette, C., Turecki, G., Global gene expression profiling of the polyamine system in suicide completers. Int. J. Neuropsychopharmacol. 14 (2011), 595–605.
58. Fiori, L.M., Gross, J.A., Turecki, G., Effects of histone modifications on increased expression of polyamine biosynthetic genes insuicide. Int. J. Neuropsychopharmacol. 15:September 8 (2012), 1161–1166, 10.1017/S1461145711001520.
59. Fuchsova, B., Alvarez Julia, A., Rizavi, H.S., Frasch, A.C., Pandey, G.N., Altered expression of neuroplasticity-related genes in the brain of depressed suicides. Neuroscience 299 (2015), 1–17.
60. Furczyk, K., Schutova, B., Michel, T.M., Thome, J., Buttner, A., The neurobiology of suicide − a review of post-mortem studies. J. Mol. Psychiatry, 1, 2013, 2.
61. Galfalvy, H., Haghighi, F., Hodgkinson, C., Goldman, D., Oquendo, M.A., Burke, A., Huang, Y.Y., Giegling, I., Rujescu, D., Bureau, A., Turecki, G., Mann, J.J., A genome-wide association study of suicidal behavior. Am. J. Med. Genet. B Neuropsychiatr. Genet. 168 (2015), 557–563.
62. Gavin, D.P., Sharma, R.P., Histone modifications, DNA methylation, and schizophrenia. Neurosci. Biobehav. Rev. 34 (2010), 882–888.
63. George, J., Goncalves, F.Q., Cristovao, G., Rodrigues, L., Meyer Fernandes, J.R., Goncalves, T., Cunha, R.A., Gomes, C.A., Different danger signals differently impact on microglial proliferation through alterations of ATP release and extracellular metabolism. Glia 63 (2015), 1636–1645.
64. Gerner, E.W., Meyskens, F.L. Jr., Polyamines and cancer: old molecules, new understanding. Nat. Rev. Cancer 4 (2004), 781–792.
65. Gomes, C., Ferreira, R., George, J., Sanches, R., Rodrigues, D.I., Goncalves, N., Cunha, R.A., Activation of microglial cells triggers a release of brain-derived neurotrophic factor (BDNF) inducing their proliferation in an adenosine A2A receptor-dependent manner: A2A receptor blockade prevents BDNF release and proliferation of microglia. J. Neuroinflammation, 10, 2013, 16.
66. Grayson, D.R., Guidotti, A., The dynamics of DNA methylation in schizophrenia and related psychiatric disorders. Neuropsychopharmacology 38 (2013), 138–166.
67. Grayson, D.R., Guidotti, A., Epigenetics in Psychiatry5-Methycytosine and 5-Hydroxymethylcytosine in Psychiatric Epigenetics, Epigenetics in Psychiatry. 2014, Academic Press, Tokyo, 209–240.
68. Griffiths, J.J., Zarate, C.A. Jr., Rasimas, J.J., Existing and novel biological therapeutics in suicide prevention. Am. J. Prev. Med. 47 (2014), S195–203.
69. Gross, J.A., Fiori, L.M., Labonte, B., Lopez, J.P., Turecki, G., Effects of promoter methylation on increased expression of polyamine biosynthetic genes in suicide. J. Psychiatr. Res. 47 (2013), 513–519.
70. Guidotti, G., Calabrese, F., Anacker, C., Racagni, G., Pariante, C.M., Riva, M.A., Glucocorticoid receptor and FKBP5 expression is altered following exposure to chronic stress: modulation by antidepressant treatment. Neuropsychopharmacology 38 (2013), 616–627.
71. Guintivano, J., Brown, T., Newcomer, A., Jones, M., Cox, O., Maher, B.S., Eaton, W.W., Payne, J.L., Wilcox, H.C., Kaminsky, Z.A., Identification and replication of a combined epigenetic and genetic biomarker predicting suicide and suicidal behaviors. Am. J. Psychiatry 171 (2014), 1287–1296.
72. Guipponi, M., Deutsch, S., Kohler, K., Perroud, N., Le Gal, F., Vessaz, M., Laforge, T., Petit, B., Jollant, F., Guillaume, S., Baud, P., Courtet, P., La Harpe, R., Malafosse, A., Genetic and epigenetic analysis of SSAT gene dysregulation in suicidal behavior. Am. J. Med. Genet. B Neuropsychiatr. Genet. 150b (2009), 799–807.
73. Gupta, S., Kim, S.Y., Artis, S., Molfese, D.L., Schumacher, A., Sweatt, J.D., Paylor, R.E., Lubin, F.D., Histone methylation regulates memory formation. J. Neurosci. 30 (2010), 3589–3599.
74. Haghighi, F., Xin, Y., Chanrion, B., O'Donnell, A.H., Ge, Y., Dwork, A.J., Arango, V., Mann, J.J., Increased DNA methylation in the suicide brain. Dialogues Clin. Neurosci. 16 (2014), 430–438.
75. Hanisch, A., Sillje, H.H., Nigg, E.A., Timely anaphase onset requires a novel spindle and kinetochore complex comprising Ska1 and Ska2. EMBO J. 25 (2006), 5504–5515.
76. Harris, E.C., Barraclough, B., Suicide as an outcome for mental disorders: a meta-analysis. Br. J. Psychiatry J. Ment. Sci. 170 (1997), 205–228.
77. Hellstrom, I.C., Dhir, S.K., Diorio, J.C., Meaney, M.J., Maternal licking regulates hippocampal glucocorticoid receptor transcription through a thyroid hormone-serotonin-NGFI-A signalling cascade. Philos. Trans. R. Soc. Lond. B: Biol. Sci. 367 (2012), 2495–2510.
78. Henneberger, C., Papouin, T., Oliet, S.H., Rusakov, D.A., Long-term potentiation depends on release of D-serine from astrocytes. Nature 463 (2010), 232–236.
79. Herman, J.P., Ostrander, M.M., Mueller, N.K., Figueiredo, H., Limbic system mechanisms of stress regulation: hypothalamo-pituitary-adrenocortical axis. Prog. Neuropsychopharmacol. Biol. Psychiatry 29 (2005), 1201–1213.
80. Hertz, L., Song, D., Li, B., Du, T., Xu, J., Gu, L., Chen, Y., Peng, L., Signal transduction in astrocytes during chronic or acute treatment with drugs (SSRIs, antibipolar drugs, GABA-ergic drugs, and benzodiazepines) ameliorating mood disorders. J. Signal Transduct., 2014, 2014, 593934.
81. Hertz, L., Rothman, D.L., Li, B., Peng, L., Chronic SSRI stimulation of astrocytic 5-HT2B receptors change multiple gene expressions/editings and metabolism of glutamate, glucose and glycogen: a potential paradigm shift. Front. Behav. Neurosci., 9, 2015, 25.
82. Hesdorffer, D.C., Berg, A.T., Kanner, A.M., An update on antiepileptic drugs and suicide: are there definitive answers yet?. Epilepsy Curr.: Am. Epilepsy Soc. 10 (2010), 137–145.
83. Hoertel, N., Franco, S., Wall, M.M., Oquendo, M.A., Kerridge, B.T., Limosin, F., Blanco, C., Mental disorders and risk of suicide attempt: a national prospective study. Mol. Psychiatry 20 (2015), 718–726.
84. Hohne, N., Poidinger, M., Merz, F., Pfister, H., Bruckl, T., Zimmermann, P., Uhr, M., Holsboer, F., Ising, M., FKBP5 genotype-dependent DNA methylation and mRNA regulation after psychosocial stress in remitted depression and healthy controls. Int. J. Neuropsychopharmacol., 18, 2015.
85. Hoptman, M.J., Volavka, J., Johnson, G., Weiss, E., Bilder, R.M., Lim, K.O., Frontal white matter microstructure, aggression, and impulsivity in men with schizophrenia: a preliminary study. Biol. Psychiatry 52 (2002), 9–14.
86. Jankord, R., Herman, J.P., Limbic regulation of hypothalamo-pituitary-adrenocortical function during acute and chronic stress. Ann. N. Y. Acad. Sci. 1148 (2008), 64–73.
87. Jollant, F., Bellivier, F., Leboyer, M., Astruc, B., Torres, S., Verdier, R., Castelnau, D., Malafosse, A., Courtet, P., Impaired decision making in suicide attempters. Am. J. Psychiatry 162 (2005), 304–310.
88. Jollant, F., Guillaume, S., Jaussent, I., Castelnau, D., Malafosse, A., Courtet, P., Impaired decision-making in suicide attempters may increase the risk of problems in affective relationships. J. Affect. Disord. 99 (2007), 59–62.
89. Jollant, F., Lawrence, N.S., Olie, E., O'Daly, O., Malafosse, A., Courtet, P., Phillips, M.L., Decreased activation of lateral orbitofrontal cortex during risky choices under uncertainty is associated with disadvantageous decision-making and suicidal behavior. NeuroImage 51 (2010), 1275–1281.
90. Jones, P.A., Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat. Rev. Genet. 13 (2012), 484–492.
91. Kallman, F.J., Heredity in Health and Mental Disease: Principles of Psychiatric Genetics in the Light of Comparative Twin Studies. 1953, Norton, New York.
92. Kamali, M., Oquendo, M.A., Mann, J.J., Understanding the neurobiology of suicidal behavior. Depress. Anxiety 14 (2001), 164–176.
93. Kaminsky, Z., Wilcox, H.C., Eaton, W.W., Van Eck, K., Kilaru, V., Jovanovic, T., Klengel, T., Bradley, B., Binder, E.B., Ressler, K.J., Smith, A.K., Epigenetic and genetic variation at SKA2 predict suicidal behavior and post-traumatic stress disorder. Transl. Psychiatry, 5, 2015, e627.
94. Kang, H.J., Kim, J.M., Lee, J.Y., Kim, S.Y., Bae, K.Y., Kim, S.W., Shin, I.S., Kim, H.R., Shin, M.G., Yoon, J.S., BDNF promoter methylation and suicidal behavior in depressive patients. J. Affect. Disord. 151 (2013), 679–685.
95. Karahoca, M., Momparler, R.L., Pharmacokinetic and pharmacodynamic analysis of 5-aza-2'-deoxycytidine (decitabine) in the design of its dose-schedule for cancer therapy. Clin. Epigenetics, 5, 2013, 3.
96. Karege, F., Vaudan, G., Schwald, M., Perroud, N., La Harpe, R., Neurotrophin levels in postmortem brains of suicide victims and the effects of antemortem diagnosis and psychotropic drugs. Brain Res. Mol. Brain Res. 136 (2005), 29–37.
97. Karsten, S.L., Kudo, L.C., Bragin, A.J., Use of peripheral blood transcriptome biomarkers for epilepsy prediction. Neurosci. Lett. 497 (2011), 213–217.
98. Kashani, P., Yousefian, S., Amini, A., Heidari, K., Younesian, S., Hatamabadi, H.R., The effect of intravenous ketamine in suicidal ideation of emergency department patients. Emergency (Tehran, Iran) 2 (2014), 36–39.
99. Kato, T., Iwamoto, K., Comprehensive DNA methylation and hydroxymethylation analysis in the human brain and its implication in mental disorders. Neuropharmacology 80 (2014), 133–139.
100. Kawamoto, E.M., Vivar, C., Camandola, S., Physiology and pathology of calcium signaling in the brain. Front. Pharmacol., 3, 2012, 61.
101. Keilp, J.G., Sackeim, H.A., Brodsky, B.S., Oquendo, M.A., Malone, K.M., Mann, J.J., Neuropsychological dysfunction in depressed suicide attempters. Am. J. Psychiatry 158 (2001), 735–741.
102. Keller, S., Sarchiapone, M., Zarrilli, F., Videtic, A., Ferraro, A., Carli, V., Sacchetti, S., Lembo, F., Angiolillo, A., Jovanovic, N., Pisanti, F., Tomaiuolo, R., Monticelli, A., Balazic, J., Roy, A., Marusic, A., Cocozza, S., Fusco, A., Bruni, C.B., Castaldo, G., Chiariotti, L., Increased BDNF promoter methylation in the Wernicke area of suicide subjects. Arch. Gen. Psychiatry 67 (2010), 258–267.
103. Keller, S., Sarchiapone, M., Zarrilli, F., Tomaiuolo, R., Carli, V., Angrisano, T., Videtic, A., Amato, F., Pero, R., di Giannantonio, M., Iosue, M., Lembo, F., Castaldo, G., Chiariotti, L., TrkB gene expression and DNA methylation state in Wernicke area does not associate with suicidal behavior. J. Affect. Disord. 135 (2011), 400–404.
104. Kelly, T.K., De Carvalho, D.D., Jones, P.A., Epigenetic modifications as therapeutic targets. Nat. Biotechnol. 28 (2010), 1069–1078.
105. Kettenmann, H., Ransom, B.R., Neuroglia. 3rd ed., 2005, Oxford University Press, Oxford.
106. Kim, C.D., Seguin, M., Therrien, N., Riopel, G., Chawky, N., Lesage, A.D., Turecki, G., Familial aggregation of suicidal behavior: a family study of male suicide completers from the general population. Am. J. Psychiatry 162 (2005), 1017–1019.
107. Kim, J.M., Kang, H.J., Bae, K.Y., Kim, S.W., Shin, I.S., Kim, H.R., Shin, M.G., Yoon, J.S., Association of BDNF promoter methylation and genotype with suicidal ideation in elderly Koreans. Am. J. Geriatr. Psychiatry 22 (2014), 989–996.
108. Kimelberg, H.K., Nedergaard, M., Functions of astrocytes and their potential as therapeutic targets. Neurotherapeutics 7 (2010), 338–353.
109. Kinde, B., Gabel, H.W., Gilbert, C.S., Griffith, E.C., Greenberg, M.E., Reading the unique DNA methylation landscape of the brain: non-CpG methylation, hydroxymethylation, and MeCP2. Proc. Natl. Acad. Sci. U. S. A. 112 (2015), 6800–6806.
110. Klempan, T.A., Rujescu, D., Merette, C., Himmelman, C., Sequeira, A., Canetti, L., Fiori, L.M., Schneider, B., Bureau, A., Turecki, G., Profiling brain expression of the spermidine/spermine N1-acetyltransferase 1 (SAT1) gene in suicide. Am. J. Med. Genet. B Neuropsychiatr. Genet. 150b (2009), 934–943.
111. Klempan, T.A., Ernst, C., Deleva, V., Labonte, B., Turecki, G., Characterization of QKI gene expression, genetics, and epigenetics in suicide victims with major depressive disorder. Biol. Psychiatry 1:November 9 (2009), 824–831, 10.1016/j.biopsych.2009.05.010.
112. Klempan, T.A., Sequeira, A., Canetti, L., Lalovic, A., Ernst, C., ffrench-Mullen, J., Turecki, G., Altered expression of genes involved in ATP biosynthesis and GABAergic neurotransmission in the ventral prefrontal cortex of suicides with and without major depression. Mol. Psychiatry 14 (2009), 175–189.
113. Klengel, T., Mehta, D., Anacker, C., Rex-Haffner, M., Pruessner, J.C., Pariante, C.M., Pace, T.W., Mercer, K.B., Mayberg, H.S., Bradley, B., Nemeroff, C.B., Holsboer, F., Heim, C.M., Ressler, K.J., Rein, T., Binder, E.B., Allele-specific FKBP5 DNA demethylation mediates gene-childhood trauma interactions. Nat. Neurosci. 16 (2013), 33–41.
114. Klonsky, E.D., May, A.M., Saffer, B.Y., Suicide, suicide attempts, and suicidal ideation. Annu. Rev. Clin. Psychol. 12 (2016), 307–330.
115. Kocerha, J., Dwivedi, Y., Brennand, K.J., Noncoding RNAs and neurobehavioral mechanisms in psychiatric disease. Mol. Psychiatry 20 (2015), 677–684.
116. Koizumi, S., Fujishita, K., Tsuda, M., Shigemoto-Mogami, Y., Inoue, K., Dynamic inhibition of excitatory synaptic transmission by astrocyte-derived ATP in hippocampal cultures. Proc. Natl. Acad. Sci. U. S. A. 100 (2003), 11023–11028.
117. Kong, H., Sha, L.L., Fan, Y., Xiao, M., Ding, J.H., Wu, J., Hu, G., Requirement of AQP4 for antidepressive efficiency of fluoxetine: implication in adult hippocampal neurogenesis. Neuropsychopharmacology 34 (2009), 1263–1276.
118. Koulakoff, A., Ezan, P., Giaume, C., Neurons control the expression of connexin 30 and connexin 43 in mouse cortical astrocytes. Glia 56 (2008), 1299–1311.
119. Koyama, Y., Functional alterations of astrocytes in mental disorders: pharmacological significance as a drug target. Front. Cell. Neurosci., 9, 2015, 261.
120. Kreisel, T., Frank, M.G., Licht, T., Reshef, R., Ben-Menachem-Zidon, O., Baratta, M.V., Maier, S.F., Yirmiya, R., Dynamic microglial alterations underlie stress-induced depressive-like behavior and suppressed neurogenesis. Mol. Psychiatry 19 (2014), 699–709.
121. Kubota, T., Miyake, K., Hirasawa, T., Epigenetic understanding of gene-environment interactions in psychiatric disorders: a new concept of clinical genetics. Clin. Epigenetics, 4, 2012, 1.
122. Kundakovic, M., Champagne, F.A., Early-life experience, epigenetics, and the developing brain. Neuropsychopharmacology 40 (2015), 141–153.
123. Kundakovic, M., Chen, Y., Costa, E., Grayson, D.R., DNA methyltransferase inhibitors coordinately induce expression of the human reelin and glutamic acid decarboxylase 67 genes. Mol. Pharmacol. 71 (2007), 644–653.
124. Labonte, B., Turecki, G., The epigenetics of suicide: explaining the biological effects of early life environmental adversity. Arch. Suicide Res.: Off. J. Int. Acad. Suicide Res. 14 (2010), 291–310.
125. Labonte, B., Suderman, M., Maussion, G., Navaro, L., Yerko, V., Mahar, I., Bureau, A., Mechawar, N., Szyf, M., Meaney, M.J., Turecki, G., Genome-wide epigenetic regulation by early-life trauma. Arch. Gen. Psychiatry 69 (2012), 722–731.
126. Labonte, B., Yerko, V., Gross, J., Mechawar, N., Meaney, M.J., Szyf, M., Turecki, G., Differential glucocorticoid receptor exon 1(B), 1(C), and 1(H) expression and methylation in suicide completers with a history of childhood abuse. Biol. Psychiatry 72:July 1 (2012), 41–48, 10.1016/j.biopsych.2012.01.034.
127. Labonte, B., Suderman, M., Maussion, G., Lopez, J.P., Navarro-Sanchez, L., Yerko, V., Mechawar, N., Szyf, M., Meaney, M.J., Turecki, G., Genome-wide methylation changes in the brains of suicide completers. Am. J. Psychiatry 170 (2013), 511–520.
128. Le-Niculescu, H., Levey, D.F., Ayalew, M., Palmer, L., Gavrin, L.M., Jain, N., Winiger, E., Bhosrekar, S., Shankar, G., Radel, M., Bellanger, E., Duckworth, H., Olesek, K., Vergo, J., Schweitzer, R., Yard, M., Ballew, A., Shekhar, A., Sandusky, G.E., Schork, N.J., Kurian, S.M., Salomon, D.R., Niculescu, A.B. 3rd, Discovery and validation of blood biomarkers for suicidality. Mol. Psychiatry 18 (2013), 1249–1264.
129. Lee, B.H., Kim, Y.K., BDNF mRNA expression of peripheral blood mononuclear cells was decreased in depressive patients who had or had not recently attempted suicide. J. Affect. Disord. 125 (2010), 369–373.
130. Lee, J., Narang, P., Enja, M., Lippmann, S., Use of ketamine in acute cases of suicidality. Innov. Clin. Neurosci. 12 (2015), 29–31.
131. Levenson, J.M., O'Riordan, K.J., Brown, K.D., Trinh, M.A., Molfese, D.L., Sweatt, J.D., Regulation of histone acetylation during memory formation in the hippocampus. J. Biol. Chem. 279 (2004), 40545–40559.
132. Levenson, J.M., Roth, T.L., Lubin, F.D., Miller, C.A., Huang, I.C., Desai, P., Malone, L.M., Sweatt, J.D., Evidence that DNA (cytosine-5) methyltransferase regulates synaptic plasticity in the hippocampus. J. Biol. Chem. 281 (2006), 15763–15773.
133. Li, B., Carey, M., Workman, J.L., The role of chromatin during transcription. Cell 128 (2007), 707–719.
134. Limon, A., Mamdani, F., Hjelm, B.E., Vawter, M.P., Sequeira, A., Targets of polyamine dysregulation in major depression and suicide: activity-dependent feedback, excitability, and neurotransmission. Neurosci. Biobehav. Rev. 66 (2016), 80–91.
135. Lipsky, R.H., Marini, A.M., Brain-derived neurotrophic factor in neuronal survival and behavior-related plasticity. Ann. N. Y. Acad. Sci. 1122 (2007), 130–143.
136. Lockwood, L.E., Su, S., Youssef, N.A., The role of epigenetics in depression and suicide: a platform for gene-environment interactions. Psychiatry Res. 228 (2015), 235–242.
137. Luger, K., Dechassa, M.L., Tremethick, D.J., New insights into nucleosome and chromatin structure: an ordered state or a disordered affair?. Nat. Rev. Mol. Cell Biol. 13 (2012), 436–447.
138. Mandelli, L., Serretti, A., Gene-environment interaction studies in suicidal behaviour. Kaschka, W.P., Rujescu, D., (eds.) Biological Aspects of Suicidal Behavior., 2016, Karger, Basel, 63–74.
139. Mann, J.J., Haghighi, F., Genes and environment: multiple pathways to psychopathology. Biol. Psychiatry 68 (2010), 403–404.
140. Mann, J.J., Arango, V.A., Avenevoli, S., Brent, D.A., Champagne, F.A., Clayton, P., Currier, D., Dougherty, D.M., Haghighi, F., Hodge, S.E., Kleinman, J., Lehner, T., McMahon, F., Moscicki, E.K., Oquendo, M.A., Pandey, G.N., Pearson, J., Stanley, B., Terwilliger, J., Wenzel, A., Candidate endophenotypes for genetic studies of suicidal behavior. Biol. Psychiatry 65 (2009), 556–563.
141. Mann, J.J., Neurobiology of suicidal behaviour. Nat. Rev. Neurosci. 4 (2003), 819–828.
142. Mann, J.J., The serotonergic system in mood disorders and suicidal behaviour. Philos. Trans. R. Soc. Lond. B Biol. Sci., 368, 2013, 20120537.
143. Martinowich, K., Lu, B., Interaction between BDNF and serotonin: role in mood disorders. Neuropsychopharmacology 33 (2008), 73–83.
144. Martinowich, K., Manji, H., Lu, B., New insights into BDNF function in depression and anxiety. Nat. Neurosci. 10 (2007), 1089–1093.
145. Maussion, G., Yang, J., Yerko, V., Barker, P., Mechawar, N., Ernst, C., Turecki, G., Regulation of a truncated form of tropomyosin-related kinase B (TrkB) by Hsa-miR-185* in frontal cortex of suicide completers. PLoS One, 7, 2012, e39301.
146. Maussion, G., Yang, J., Suderman, M., Diallo, A., Nagy, C., Arnovitz, M., Mechawar, N., Turecki, G., Functional DNA methylation in a transcript specific 3'UTR region of TrkB associates with suicide. Epigenetics 9 (2014), 1061–1070.
147. Maze, I., Noh, K.M., Allis, C.D., Histone regulation in the CNS: basic principles of epigenetic plasticity. Neuropsychopharmacology 38 (2013), 3–22.
148. McGirr, A., Alda, M., Seguin, M., Cabot, S., Lesage, A., Turecki, G., Familial aggregation of suicide explained by cluster B traits: a three-group family study of suicide controlling for major depressive disorder. Am.J. Psychiatry 166 (2009), 1124–1134.
149. McGowan, P.O., Szyf, M., The epigenetics of social adversity in early life: implications for mental health outcomes. Neurobiol. Dis. 39 (2010), 66–72.
150. McGowan, P.O., Sasaki, A., D'Alessio, A.C., Dymov, S., Labonte, B., Szyf, M., Turecki, G., Meaney, M.J., Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat. Neurosci. 12 (2009), 342–348.
151. McNally, L., Bhagwagar, Z., Hannestad, J., Inflammation, glutamate, and glia in depression: a literature review. CNS Spectr. 13 (2008), 501–510.
152. Mehta, D., Gonik, M., Klengel, T., Rex-Haffner, M., Menke, A., Rubel, J., Mercer, K.B., Putz, B., Bradley, B., Holsboer, F., Ressler, K.J., Muller-Myhsok, B., Binder, E.B., Using polymorphisms in FKBP5 to define biologically distinct subtypes of posttraumatic stress disorder: evidence from endocrine and gene expression studies. Arch. Gen. Psychiatry 68 (2011), 901–910.
153. Melhem, N.M., Keilp, J.G., Porta, G., Oquendo, M.A., Burke, A., Stanley, B., Cooper, T.B., Mann, J.J., Brent, D.A., Blunted HPA axis activity in suicide attempters compared to those at high risk for suicidal behavior. Neuropsychopharmacology 41 (2016), 1447–1456.
154. Menke, A., Klengel, T., Rubel, J., Bruckl, T., Pfister, H., Lucae, S., Uhr, M., Holsboer, F., Binder, E.B., Genetic variation in FKBP5 associated with the extent of stress hormone dysregulation in major depression. Genes Brain Behav. 12 (2013), 289–296.
155. Merali, Z., Du, L., Hrdina, P., Palkovits, M., Faludi, G., Poulter, M.O., Anisman, H., Dysregulation in the suicide brain: mRNA expression of corticotropin-releasing hormone receptors and GABA(A) receptor subunits in frontal cortical brain region. J. Neurosci. 24 (2004), 1478–1485.
156. Minichiello, L., TrkB signalling pathways in LTP and learning. Nat. Rev. Neurosci. 10 (2009), 850–860.
157. Moore, L.D., Le, T., Fan, G., DNA methylation and its basic function. Neuropsychopharmacology 38 (2013), 23–38.
158. Munkholm, K., Peijs, L., Kessing, L.V., Vinberg, M., Reduced mRNA expression of PTGDS in peripheral blood mononuclear cells of rapid-cycling bipolar disorder patients compared with healthy control subjects. Int. J. Neuropsychopharmacol., 18, 2015.
159. Nagy, C., Suderman, M., Yang, J., Szyf, M., Mechawar, N., Ernst, C., Turecki, G., Astrocytic abnormalities and global DNA methylation patterns in depression and suicide. Mol. Psychiatry 20 (2015), 320–328.
160. Nagy, C., Torres-Platas, S.G., Mechawar, N., Turecki, G., Repression of astrocytic connexins in cortical and subcortical brain regions and prefrontal enrichment of H3K9me3 in depression and suicide. Int. J. Neuropsychopharmacol., 2016.
161. Narayan, P., Dragunow, M., Pharmacology of epigenetics in brain disorders. Br. J. Pharmacol. 159 (2010), 285–303.
162. Nebbioso, A., Carafa, V., Benedetti, R., Altucci, L., Trials with ‘epigenetic' drugs: an update. Mol. Oncol. 6 (2012), 657–682.
163. Newman, E.A., Glial cell inhibition of neurons by release of ATP. J. Neurosci. 23 (2003), 1659–1666.
164. Nghia, N.A., Hirasawa, T., Kasai, H., Obata, C., Moriishi, K., Mochizuki, K., Koizumi, S., Kubota, T., Long-term imipramine treatment increases N-methyl-D-aspartate receptor activity and expression via epigenetic mechanisms. Eur. J. Pharmacol. 752 (2015), 69–77.
165. Niciu, M.J., Grunschel, B.D., Corlett, P.R., Pittenger, C., Bloch, M.H., Two cases of delayed-onset suicidal ideation, dysphoria and anxiety after ketamine infusion in patients with obsessive-compulsive disorder and a history of major depressive disorder. J. Psychopharmacol. (Oxford, England) 27 (2013), 651–654.
166. Niculescu, A.B., Levey, D., Le-Niculescu, H., Niculescu, E., Kurian, S.M., Salomon, D., Psychiatric blood biomarkers: avoiding jumping to premature negative or positive conclusions. Mol. Psychiatry 20 (2015), 286–288.
167. Niculescu, A.B., Levey, D.F., Phalen, P.L., Le-Niculescu, H., Dainton, H.D., Jain, N., Belanger, E., James, A., George, S., Weber, H., Graham, D.L., Schweitzer, R., Ladd, T.B., Learman, R., Niculescu, E.M., Vanipenta, N.P., Khan, F.N., Mullen, J., Shankar, G., Cook, S., Humbert, C., Ballew, A., Yard, M., Gelbart, T., Shekhar, A., Schork, N.J., Kurian, S.M., Sandusky, G.E., Salomon, D.R., Understanding and predicting suicidality using a combined genomic and clinical risk assessment approach. Mol. Psychiatry 20 (2015), 1266–1285.
168. Olk, S., Zoidl, G., Dermietzel, R., Connexins, cell motility, and the cytoskeleton. Cell Motil. Cytoskelet. 66 (2009), 1000–1016.
169. Oquendo, M.A., Galfalvy, H.C., Currier, D., Grunebaum, M.F., Sher, L., Sullivan, G.M., Burke, A.K., Harkavy-Friedman, J., Sublette, M.E., Parsey, R.V., Mann, J.J., Treatment of suicide attempters with bipolar disorder: a randomized clinical trial comparing lithium and valproate in the prevention of suicidal behavior. Am. J. Psychiatry 168 (2011), 1050–1056.
170. Paakinaho, V., Makkonen, H., Jaaskelainen, T., Palvimo, J.J., Glucocorticoid receptor activates poised FKBP51 locus through long-distance interactions. Mol. Endocrinol. (Baltimore, Md.) 24 (2010), 511–525.
171. Pabba, M., Sibille, E., GABA, depression and suicide. Kaschka, W.P., Rujescu, D., (eds.) Biological Aspects of Suicidal Behavior., 2016, Karger, Basel, 37–50.
172. Panatier, A., Theodosis, D.T., Mothet, J.P., Touquet, B., Pollegioni, L., Poulain, D.A., Oliet, S.H., Glia-derived D-serine controls NMDA receptor activity and synaptic memory. Cell 125 (2006), 775–784.
173. Pandey, G.N., Dwivedi, Y., What can post-mortem studies tell us about the pathoetiology of suicide?. Future Neurol. 5 (2010), 701–720.
174. Pandey, G.N., Ren, X., Rizavi, H.S., Conley, R.R., Roberts, R.C., Dwivedi, Y., Brain-derived neurotrophic factor and tyrosine kinase B receptor signalling in post-mortem brain of teenage suicide victims. Int. J. Neuropsychopharmacol. 11 (2008), 1047–1061.
175. Pandey, G.N., Rizavi, H.S., Ren, X., Fareed, J., Hoppensteadt, D.A., Roberts, R.C., Conley, R.R., Dwivedi, Y., Proinflammatory cytokines in the prefrontal cortex of teenage suicide victims. J. Psychiatr. Res. 46 (2012), 57–63.
176. Pandey, G.N., Biological basis of suicide and suicidal behavior. Bipolar Disord. 15 (2013), 524–541.
177. Pankratov, Y., Lalo, U., Role for astroglial alpha1-adrenoreceptors in gliotransmission and control of synaptic plasticity in the neocortex. Front. Cell. Neurosci., 9, 2015, 230.
178. Park, H., Poo, M.M., Neurotrophin regulation of neural circuit development and function. Nat. Rev. Neurosci. 14 (2013), 7–23.
179. Parkhurst, C.N., Yang, G., Ninan, I., Savas, J.N., Yates, J.R. 3rd, Lafaille, J.J., Hempstead, B.L., Littman, D.R., Gan, W.B., Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor. Cell 155 (2013), 1596–1609.
180. Pascual, O., Casper, K.B., Kubera, C., Zhang, J., Revilla-Sanchez, R., Sul, J.Y., Takano, H., Moss, S.J., McCarthy, K., Haydon, P.G., Astrocytic purinergic signaling coordinates synaptic networks. Science 310 (2005), 113–116.
181. Pascual, O., Ben Achour, S., Rostaing, P., Triller, A., Bessis, A., Microglia activation triggers astrocyte-mediated modulation of excitatory neurotransmission. Proc. Natl. Acad. Sci. U. S. A. 109 (2012), E197–205.
182. Pastor, W.A., Aravind, L., Rao, A., TETonic shift: biological roles of TET proteins in DNA demethylation and transcription. Nat. Rev. Mol. Cell Biol. 14 (2013), 341–356.
183. Pearson-Leary, J., Osborne, D.M., McNay, E.C., Role of glia in stress-induced enhancement and impairment of memory. Front. Integr. Neurosci., 9, 2015, 63.
184. Pedersen, N.L., Fiske, A., Genetic influences on suicide and nonfatal suicidal behavior: twin study findings. Eur. Psychiatry 25 (2010), 264–267.
185. Pena-Hernandez, R., Marques, M., Hilmi, K., Zhao, T., Saad, A., Alaoui-Jamali, M.A., del Rincon, S.V., Ashworth, T., Roy, A.L., Emerson, B.M., Witcher, M., Genome-wide targeting of the epigenetic regulatory protein CTCF to gene promoters by the transcription factor TFII-I. Proc. Natl. Acad. Sci. U. S. A. 112 (2015), E677–686.
186. Perez-Ortiz, J.M., Garcia-Gutierrez, M.S., Navarrete, F., Giner, S., Manzanares, J., Gene and protein alterations of FKBP5 and glucocorticoid receptor in the amygdala of suicide victims. Psychoneuroendocrinology 38 (2013), 1251–1258.
187. Poulter, M.O., Du, L., Weaver, I.C., Palkovits, M., Faludi, G., Merali, Z., Szyf, M., Anisman, H., GABAA receptor promoter hypermethylation in suicide brain: implications for the involvement of epigenetic processes. Biol. Psychiatry 64 (2008), 645–652.
188. Price, R.B., Mathew, S.J., Does ketamine have anti-suicidal properties? Current status and future directions. CNS Drugs 29 (2015), 181–188.
189. Price, R.B., Iosifescu, D.V., Murrough, J.W., Chang, L.C., Al Jurdi, R.K., Iqbal, S.Z., Soleimani, L., Charney, D.S., Foulkes, A.L., Mathew, S.J., Effects of ketamine on explicit and implicit suicidal cognition: a randomized controlled trial in treatment-resistant depression. Depress. Anxiety 31 (2014), 335–343.
190. Qi, X.R., Kamphuis, W., Wang, S., Wang, Q., Lucassen, P.J., Zhou, J.N., Swaab, D.F., Aberrant stress hormone receptor balance in the human prefrontal cortex and hypothalamic paraventricular nucleus of depressed patients. Psychoneuroendocrinology 38 (2013), 863–870.
191. Raine, A., Meloy, J.R., Bihrle, S., Stoddard, J., LaCasse, L., Buchsbaum, M.S., Reduced prefrontal and increased subcortical brain functioning assessed using positron emission tomography in predatory and affective murderers. Behav. Sci. Law 16 (1998), 319–332.
192. Rajkowska, G., Stockmeier, C.A., Astrocyte pathology in major depressive disorder: insights from human postmortem brain tissue. Curr. Drug Targets 14 (2013), 1225–1236.
193. Rao, P., Benito, E., Fischer, A., MicroRNAs as biomarkers for CNS disease. Front. Mol. Neurosci., 6, 2013, 39.
194. Raust, A., Slama, F., Mathieu, F., Roy, I., Chenu, A., Koncke, D., Fouques, D., Jollant, F., Jouvent, E., Courtet, P., Leboyer, M., Bellivier, F., Prefrontal cortex dysfunction in patients with suicidal behavior. Psychol. Med. 37 (2007), 411–419.
195. Rebola, N., Simoes, A.P., Canas, P.M., Tome, A.R., Andrade, G.M., Barry, C.E., Agostinho, P.M., Lynch, M.A., Cunha, R.A., Adenosine A2A receptors control neuroinflammation and consequent hippocampal neuronal dysfunction. J. Neurochem. 117 (2011), 100–111.
196. Reinstatler, L., Youssef, N.A., Ketamine as a potential treatment for suicidal ideation: a systematic review of the literature. Drugs R&D 15 (2015), 37–43.
197. Reus, G.Z., Abelaira, H.M., dos Santos, M.A., Carlessi, A.S., Tomaz, D.B., Neotti, M.V., Liranco, J.L., Gubert, C., Barth, M., Kapczinski, F., Quevedo, J., Ketamine and imipramine in the nucleus accumbens regulate histone deacetylation induced by maternal deprivation and are critical for associated behaviors. Behav. Brain Res. 256 (2013), 451–456.
198. Rial, D., Lemos, C., Pinheiro, H., Duarte, J.M., Goncalves, F.Q., Real, J.I., Prediger, R.D., Goncalves, N., Gomes, C.A., Canas, P.M., Agostinho, P., Cunha, R.A., Depression as a glial-based synaptic dysfunction. Front. Cell. Neurosci., 9, 2015, 521.
199. Rice, L., Waters, C.E., Eccles, J., Garside, H., Sommer, P., Kay, P., Blackhall, F.H., Zeef, L., Telfer, B., Stratford, I., Clarke, R., Singh, D., Stevens, A., White, A., Ray, D.W., Identification and functional analysis of SKA2 interaction with the glucocorticoid receptor. J. Endocrinol. 198 (2008), 499–509.
200. Rollins, B., Martin, M.V., Morgan, L., Vawter, M.P., Analysis of whole genome biomarker expression in blood and brain. Am. J. Med. Genet. B Neuropsychiatr. Genet. 153b (2010), 919–936.
201. Rose, C.R., Blum, R., Pichler, B., Lepier, A., Kafitz, K.W., Konnerth, A., Truncated TrkB-T1 mediates neurotrophin-evoked calcium signalling in glia cells. Nature 426 (2003), 74–78.
202. Roy, A., Segal, N.L., Suicidal behavior in twins: a replication. J. Affect. Disord. 66 (2001), 71–74.
203. Roy, A., Segal, N.L., Centerwall, B.S., Robinette, C.D., Suicide in twins. Arch. Gen. Psychiatry 48 (1991), 29–32.
204. Roy, A., Segal, N.L., Sarchiapone, M., Attempted suicide among living co-twins of twin suicide victims. Am. J. Psychiatry 152 (1995), 1075–1076.
205. Roy, A., Gorodetsky, E., Yuan, Q., Goldman, D., Enoch, M.A., Interaction of FKBP5, a stress-related gene, with childhood trauma increases the risk for attempting suicide. Neuropsychopharmacology 35 (2010), 1674–1683.
206. Roy, A., Hodgkinson, C.A., Deluca, V., Goldman, D., Enoch, M.A., Two HPA axis genes, CRHBP and FKBP5, interact with childhood trauma to increase the risk for suicidal behavior. J. Psychiatr. Res. 46 (2012), 72–79.
207. Roy, A., Gene–environment interaction and suicidal behavior. Dwivedi, Y., (eds.) The Neurobiological Basis of Suicide, 2012, CRC Press/Taylor & Francis, Boca Raton (FL).
208. Sadeh, N., Wolf, E.J., Logue, M.W., Hayes, J.P., Stone, A., Griffin, L.M., Schichman, S.A., Miller, M.W., Epigenetic variation at ska2 predicts suicide phenotypes and internalizing psychopathology. Depress. Anxiety 33 (2016), 308–315.
209. Satterlee, J.S., Basanta-Sanchez, M., Blanco, S., Li, J.B., Meyer, K., Pollock, J., Sadri-Vakili, G., Rybak-Wolf, A., Novel RNA modifications in the nervous system: form and function. J. Neurosci. 34 (2014), 15170–15177.
210. Scianni, M., Antonilli, L., Chece, G., Cristalli, G., Di Castro, M.A., Limatola, C., Maggi, L., Fractalkine (CX3CL1) enhances hippocampal N-methyl-D-aspartate receptor (NMDAR) function via D-serine and adenosine receptor type A2 (A2AR) activity. J. Neuroinflammation, 10, 2013, 108.
211. Sequeira, A., Gwadry, F.G., Ffrench-Mullen, J.M., Canetti, L., Gingras, Y., Casero, R.A. Jr., Rouleau, G., Benkelfat, C., Turecki, G., Implication of SSAT by gene expression and genetic variation in suicide and major depression. Arch. Gen. Psychiatry 63 (2006), 35–48.
212. Sequeira, A., Klempan, T., Canetti, L., ffrench-Mullen, J., Benkelfat, C., Rouleau, G.A., Turecki, G., Patterns of gene expression in the limbic system of suicides with and without major depression. Mol. Psychiatry 12 (2007), 640–655.
213. Sequeira, A., Mamdani, F., Ernst, C., Vawter, M.P., Bunney, W.E., Lebel, V., Rehal, S., Klempan, T., Gratton, A., Benkelfat, C., Rouleau, G.A., Mechawar, N., Turecki, G., Global brain gene expression analysis links glutamatergic and GABAergic alterations to suicide and major depression. PLoS One, 4, 2009, e6585.
214. Serrano, A., Haddjeri, N., Lacaille, J.C., Robitaille, R., GABAergic network activation of glial cells underlies hippocampal heterosynaptic depression. J. Neurosci. 26 (2006), 5370–5382.
215. Sharma, R.P., Blood chromatin as a biosensor of the epigenetic milieu: a tool for studies in living psychiatric patients. Epigenomics 4 (2012), 551–559.
216. Slap, G., Goodman, E., Huang, B., Adoption as a risk factor for attempted suicide during adolescence. Pediatrics, 108, 2001, E30.
217. Smalheiser, N.R., Lugli, G., Rizavi, H.S., Torvik, V.I., Turecki, G., Dwivedi, Y., MicroRNA expression is down-regulated and reorganized in prefrontal cortex of depressed suicide subjects. PLoS One, 7, 2012, e33201.
218. Smith, S.M., Vale, W.W., The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress. Dialogues Clin. Neurosci. 8 (2006), 383–395.
219. Speckens, A.E., Hawton, K., Social problem solving in adolescents with suicidal behavior: a systematic review. Suicide Life-Threat. Behav. 35 (2005), 365–387.
220. Sun, J.D., Liu, Y., Yuan, Y.H., Li, J., Chen, N.H., Gap junction dysfunction in the prefrontal cortex induces depressive-like behaviors in rats. Neuropsychopharmacology 37 (2012), 1305–1320.
221. Sun, H., Kennedy, P.J., Nestler, E.J., Epigenetics of the depressed brain: role of histone acetylation and methylation. Neuropsychopharmacology 38 (2013), 124–137.
222. Sun, W., Zang, L., Shu, Q., Li, X., From development to diseases: the role of 5hmC in brain. Genomics 104 (2014), 347–351.
223. Supriyanto, I., Sasada, T., Fukutake, M., Asano, M., Ueno, Y., Nagasaki, Y., Shirakawa, O., Hishimoto, A., Association of FKBP5 gene haplotypes with completed suicide in the Japanese population. Prog. Neuropsychopharmacol. Biol. Psychiatry 35 (2011), 252–256.
224. Szyf, M., Epigenetics, DNA methylation, and chromatin modifying drugs. Annu. Rev. Pharmacool. Toxicol. 49 (2009), 243–263.
225. Tan, L., Shi, Y.G., Tet family proteins and 5-hydroxymethylcytosine in development and disease. Development (Cambridge, England) 139 (2012), 1895–1902.
226. Tatro, E.T., Everall, I.P., Kaul, M., Achim, C.L., Modulation of glucocorticoid receptor nuclear translocation in neurons by immunophilins FKBP51 and FKBP52: implications for major depressive disorder. Brain Res. 1286 (2009), 1–12.
227. Thakurta, R.G., Das, R., Bhattacharya, A.K., Saha, D., Sen, S., Singh, O.P., Bisui, B., Rapid response with ketamine on suicidal cognition in resistant depression. Indian J. Psychol. Med. 34 (2012), 170–175.
228. Torres-Platas, S.G., Hercher, C., Davoli, M.A., Maussion, G., Labonte, B., Turecki, G., Mechawar, N., Astrocytic hypertrophy in anterior cingulate white matter of depressed suicides. Neuropsychopharmacology 36 (2011), 2650–2658.
229. Tripp, A., Oh, H., Guilloux, J.P., Martinowich, K., Lewis, D.A., Sibille, E., Brain-derived neurotrophic factor signaling and subgenual anterior cingulate cortex dysfunction in major depressive disorder. Am. J. Psychiatry 169 (2012), 1194–1202.
230. Tsankova, N.M., Berton, O., Renthal, W., Kumar, A., Neve, R.L., Nestler, E.J., Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat. Neurosci. 9 (2006), 519–525.
231. Tsankova, N., Renthal, W., Kumar, A., Nestler, E.J., Epigenetic regulation in psychiatric disorders. Nat. Rev. Neurosci. 8 (2007), 355–367.
232. Turecki, G., The molecular bases of the suicidal brain. Nat. Rev. Neurosci. 15 (2014), 802–816.
233. van Heeringen, C., Bijttebier, S., Godfrin, K., Suicidal brains: a review of functional and structural brain studies in association with suicidal behaviour. Neurosci. Biobehav. Rev. 35 (2011), 688–698.
234. van Heeringen, K., The neurobiology of suicide and suicidality. Can. J. Psychiatry 48 (2003), 292–300.
235. Van Heeringen, C., Marusic, A., Understanding the suicidal brain. Br. J. Psychiatry: J. Ment. Sci. 183 (2003), 282–284.
236. Venkatesh, S., Workman, J.L., Histone exchange, chromatin structure and the regulation of transcription. Nat. Rev. Mol. Cell Biol. 16 (2015), 178–189.
237. Vermeer, H., Hendriks-Stegeman, B.I., van der Burg, B., van Buul-Offers, S.C., Jansen, M., Glucocorticoid-induced increase in lymphocytic FKBP51 messenger ribonucleic acid expression: a potential marker for glucocorticoid sensitivity, potency, and bioavailability. J. Clin. Endocrinol. Metab. 88 (2003), 277–284.
238. Vialou, V., Feng, J., Robison, A.J., Nestler, E.J., Epigenetic mechanisms of depression and antidepressant action. Annu. Rev. Pharmacool. Toxicol. 53 (2013), 59–87.
239. WHO, 2014. Preventing suicide: A global imperative. http://www.who.int/mental_health/suicide[HYPHEN]prevention/world_report_2014/en/.
240. Weaver, I.C., Cervoni, N., Champagne, F.A., D'Alessio, A.C., Sharma, S., Seckl, J.R., Dymov, S., Szyf, M., Meaney, M.J., Epigenetic programming by maternal behavior. Nat. Neurosci. 7 (2004), 847–854.
241. Weaver, I.C., D'Alessio, A.C., Brown, S.E., Hellstrom, I.C., Dymov, S., Sharma, S., Szyf, M., Meaney, M.J., The transcription factor nerve growth factor-inducible protein a mediates epigenetic programming: altering epigenetic marks by immediate-early genes. J. Neurosci. 27 (2007), 1756–1768.
242. Wilkinson, S.T., Sanacora, G., Ketamine: a potential rapid-acting antisuicidal agent?. Depress. Anxiety 33 (2016), 711–717.
243. Wilkinson, M.B., Xiao, G., Kumar, A., LaPlant, Q., Renthal, W., Sikder, D., Kodadek, T.J., Nestler, E.J., Imipramine treatment and resiliency exhibit similar chromatin regulation in the mouse nucleus accumbens in depression models. J. Neurosci. 29 (2009), 7820–7832.
244. Willour, V.L., Chen, H., Toolan, J., Belmonte, P., Cutler, D.J., Goes, F.S., Zandi, P.P., Lee, R.S., MacKinnon, D.F., Mondimore, F.M., Schweizer, B., DePaulo, J.R. Jr., Gershon, E.S., McMahon, F.J., Potash, J.B., Family-based association of FKBP5 in bipolar disorder. Mol. Psychiatry 14 (2009), 261–268.
245. Wu, X., Chen, P.S., Dallas, S., Wilson, B., Block, M.L., Wang, C.C., Kinyamu, H., Lu, N., Gao, X., Leng, Y., Chuang, D.M., Zhang, W., Lu, R.B., Hong, J.S., Histone deacetylase inhibitors up-regulate astrocyte GDNF and BDNF gene transcription and protect dopaminergic neurons. Int. J. Neuropsychopharmacol. 11 (2008), 1123–1134.
246. Yang, Y., Ge, W., Chen, Y., Zhang, Z., Shen, W., Wu, C., Poo, M., Duan, S., Contribution of astrocytes to hippocampal long-term potentiation through release of D-serine. Proc. Natl. Acad. Sci. U. S. A. 100 (2003), 15194–15199.
247. Yao, I., Iida, J., Nishimura, W., Hata, Y., Synaptic localization of SAPAP1, a synaptic membrane-associated protein. Genes Cells: Devot. Mol. Cell. Mech. 8 (2003), 121–129.
248. Yu, H., Su, Y., Shin, J., Zhong, C., Guo, J.U., Weng, Y.L., Gao, F., Geschwind, D.H., Coppola, G., Ming, G.L., Song, H., Tet3 regulates synaptic transmission and homeostatic plasticity via DNA oxidation and repair. Nat. Neurosci. 18 (2015), 836–843.
249. Zai, C.C., Genetic factors and suicidal behavior. Dwivedi, Y., (eds.) The Neurobiological Basis of Suicide, 2012, CRC Press/Taylor & Francis, Boca Raton (FL) (Frontiers in Neuroscience).
250. Zannas, A.S., Binder, E.B., Gene-environment interactions at the FKBP5 locus: sensitive periods, mechanisms and pleiotropism. Genes Brain Behav. 13 (2014), 25–37.
251. Zannas, A.S., Wiechmann, T., Gassen, N.C., Binder, E.B., Gene-stress-epigenetic regulation of FKBP5: clinical and translational implications. Neuropsychopharmacology 41 (2016), 261–274.
252. Zhan, Y., Paolicelli, R.C., Sforazzini, F., Weinhard, L., Bolasco, G., Pagani, F., Vyssotski, A.L., Bifone, A., Gozzi, A., Ragozzino, D., Gross, C.T., Deficient neuron-microglia signaling results in impaired functional brain connectivity and social behavior. Nat. Neurosci. 17 (2014), 400–406.
253. Zhang, J.M., Wang, H.K., Ye, C.Q., Ge, W., Chen, Y., Jiang, Z.L., Wu, C.P., Poo, M.M., Duan, S., ATP released by astrocytes mediates glutamatergic activity-dependent heterosynaptic suppression. Neuron 40 (2003), 971–982.
254. Zheleznyakova, G.Y., Nilsson, E.K., Kiselev, A.V., Maretina, M.A., Tishchenko, L.I., Fredriksson, R., Baranov, V.S., Schioth, H.B., Methylation levels of SLC23A2 and NCOR2 genes correlate with spinal muscular atrophy severity. PLoS One, 10, 2015, e0121964.
255. Zimmermann, P., Bruckl, T., Nocon, A., Pfister, H., Binder, E.B., Uhr, M., Lieb, R., Moffitt, T.E., Caspi, A., Holsboer, F., Ising, M., Interaction of FKBP5 gene variants and adverse life events in predicting depression onset: results from a 10-year prospective community study. Am. J. Psychiatry 168 (2011), 1107–1116.
256. Zuo, L., Tan, Y., Wang, Z., Wang, K.S., Zhang, X., Chen, X., Li, C.S., Wang, T., Luo, X., Long noncoding RNAs in psychiatric disorders. Psychiatr. Genet. 26 (2016), 109–116.